FDA Approves Trial for Drug to Treat Blood Clots in Coronavirus Patients
Mike Sherman T’92, CEO of Chimerix, discusses DSTAT—a drug the company is developing that has been approved for trial by the FDA and could potentially be used to treat COVID-19 patients.